Alan Rudolph
Chief Executive Officer at PhotonPharma, Inc.
Profile
Alan S.
Rudolph is currently the Chief Executive Officer & Director at PhotonPharma, Inc. He is also serving as the Secretary & Director at Colorado BioScience Association and as a Director at Innosphere Advisors, Inc. Additionally, he holds the position of Vice President of Research at Colorado State University since 2013.
Previously, Dr. Rudolph served as the Chairman, President & Chief Executive Officer at Adlyfe, Inc. He was also the Chairman of Cellphire, Inc. from 2013 to 2016.
In 2013, he briefly worked as the Director-Biological & Chemical Defense at the U.S.
Department of Homeland Security.
He also held the position of Co-President at Sheridan Ross PC.
Dr. Rudolph completed his MBA from George Washington University.
He obtained his undergraduate degree from the University of Michigan in 1981.
He also holds a doctorate degree from the University of California.
Alan Rudolph active positions
| Companies | Position | Start |
|---|---|---|
Colorado BioScience Association
 Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Director/Board Member | - |
Innosphere Advisors, Inc /Venture Capital/
 Innosphere Advisors, Inc /Venture Capital/ Investment ManagersFinance Innosphere Advisors Inc (Innosphere Ventures) is a venture capital firm founded in 1998. The firm is headquartered in Fort Collins, Colorado. | Director/Board Member | - |
| Colorado State University | Corporate Officer/Principal | 2013-09-30 |
PhotonPharma, Inc.
 PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is a company that is developing a personalized therapeutic cancer vaccine called Innocell. The company is based in Fort Collins, CO, at the Research Innovation Center of Colorado State University. The vaccine is designed using autologous tumor tissue and a photochemical inactivation platform that uses riboflavin and UV light to render tumor cells incapable of replication while still being able to metabolize, express proteins, present antigen, and stimulate immune recognition and response mechanisms. The company has demonstrated the ability of this technology to prevent metastatic tumor formation, reduce the growth of tumors, and stimulate cellular immune response pathways in preclinical development animal models. The company was founded in 2018 by Raymond Goodrich, and the CEO is Alan S. Rudolph. | Chief Executive Officer | - |
Former positions of Alan Rudolph
| Companies | Position | End |
|---|---|---|
Cellphire, Inc.
 Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Chairman | 2016-06-29 |
| U.S. Department of Homeland Security | Corporate Officer/Principal | 2013-10-29 |
Sheridan Ross PC
 Sheridan Ross PC Miscellaneous Commercial ServicesCommercial Services Sheridan Ross PC operates as an intellectual property law firm. The company was founded in 1954 and is headquartered in Denver, CO. | President | - |
Adlyfe, Inc.
 Adlyfe, Inc. Medical DistributorsDistribution Services Adlyfe, Inc. is a privately held early stage biotechnology company that utilizes novel and proprietary peptide technology to develop solutions for early detection of protein misfolding diseases. It offers Pronucleon, a platform technology using custom-synthesized peptides that allow signal amplification to map the surface of rare proteins. The firm's technology detects the sequence and the conformation of amyloid proteins, to create sensitive and specific detection methods that allow early stage diagnosis and disease progression monitoring. Adlyfe was founded in 2003 by Richard O. Cliff and is headquartered in Rockville, MD. | Chairman | - |
Training of Alan Rudolph
| University of California | Doctorate Degree |
| George Washington University | Masters Business Admin |
| University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Adlyfe, Inc.
Adlyfe, Inc. Medical DistributorsDistribution Services Adlyfe, Inc. is a privately held early stage biotechnology company that utilizes novel and proprietary peptide technology to develop solutions for early detection of protein misfolding diseases. It offers Pronucleon, a platform technology using custom-synthesized peptides that allow signal amplification to map the surface of rare proteins. The firm's technology detects the sequence and the conformation of amyloid proteins, to create sensitive and specific detection methods that allow early stage diagnosis and disease progression monitoring. Adlyfe was founded in 2003 by Richard O. Cliff and is headquartered in Rockville, MD. | Distribution Services |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Commercial Services |
Sheridan Ross PC
Sheridan Ross PC Miscellaneous Commercial ServicesCommercial Services Sheridan Ross PC operates as an intellectual property law firm. The company was founded in 1954 and is headquartered in Denver, CO. | Commercial Services |
Innosphere Advisors, Inc /Venture Capital/
Innosphere Advisors, Inc /Venture Capital/ Investment ManagersFinance Innosphere Advisors Inc (Innosphere Ventures) is a venture capital firm founded in 1998. The firm is headquartered in Fort Collins, Colorado. | Finance |
Cellphire, Inc.
Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Health Technology |
| U.S. Department of Homeland Security | Government |
PhotonPharma, Inc.
PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is a company that is developing a personalized therapeutic cancer vaccine called Innocell. The company is based in Fort Collins, CO, at the Research Innovation Center of Colorado State University. The vaccine is designed using autologous tumor tissue and a photochemical inactivation platform that uses riboflavin and UV light to render tumor cells incapable of replication while still being able to metabolize, express proteins, present antigen, and stimulate immune recognition and response mechanisms. The company has demonstrated the ability of this technology to prevent metastatic tumor formation, reduce the growth of tumors, and stimulate cellular immune response pathways in preclinical development animal models. The company was founded in 2018 by Raymond Goodrich, and the CEO is Alan S. Rudolph. | Health Technology |
- Stock Market
- Insiders
- Alan Rudolph
